patient preferences and perspectives regarding reducing alcohol consumption: role of nalmefene
Klicks: 215
ID: 153987
2014
Artikelqualität & Leistungskennzahlen
Gesamtqualität
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Leser-Engagement
Steady Performance
30.0
/100
215 Aufrufe
45 Leser
KI-Qualitätsbewertung
Nicht analysiert
Readership in this journal
SteadyRanked #41 of 79 articles by views in the journal of craniofacial surgery
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Amandine Luquiens, Henri-Jean Aubin INSERM U669, Université Paris Sud, Hôpital Paul Brousse, Assistance Publique – Hôpitaux de Paris (AP-HP), Villejuif, France Abstract: Alcohol use disorder is a major public health issue. The absolute mortality burden of alcohol-attributable death has increased over the last 20 years. However, access to care remains very poor and many people with alcohol use disorder are untreated. The main limiting factor for access to care in alcohol use disorder appears to be the reluctance to engage in abstinence. Risk reduction is a developing approach in the treatment of alcohol use disorders, drawing its inspiration, with quite a delay, from the decades-long dominant approach in other substance use disorders. A paradigm shift has recently occurred that places more of an emphasis on reducing alcohol as a therapeutic strategy for patients with alcohol use disorder, to better meet the patients’ preferences and needs. The development and recent approval of nalmefene, in alcohol-dependent adults with a high drinking risk level, contributes to enlarging the therapeutic arsenal for alcohol dependence, strengthening the legitimacy of alcohol reduction strategies. Keywords: harm reduction, alcohol use disorder, therapeutic goal, patients’ satisfaction
| Referenzschlüssel |
a2014patientpatient
Verwenden Sie diesen Schlüssel zum automatischen Zitieren im Manuskript bei Verwendung von
SciMatic Manuscript Manager oder Thesis Manager
|
|---|---|
| Autoren | ;Luquiens A;Aubin HJ |
| Zeitschrift | the journal of craniofacial surgery |
| Jahr | 2014 |
| DOI |
DOI nicht gefunden
|
| URL | |
| Schlüsselwörter |
Zitationen
Keine Zitationen gefunden. Um eine Zitation hinzuzufügen, kontaktieren Sie den Administrator unter info@scimatic.org
Kommentare
Noch keine Kommentare. Seien Sie der Erste, der diesen Artikel kommentiert.